Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools

Clinical Genetics

Volumn 78, Issue 1, 2010, Pages 21-31

  Ioannou, L ^a,b   Massie, J ^c,d   Lewis, S ^a   Petrou, V ^e   Gason, A ^a,f   Metcalfe, S ^d,f   Aitken, M A ^a,d   Bankier, A ^e   Delatycki, M B ^a,b,d,e,g  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e Genetic Health Services Victoria   (Australia)

^f Genetics Education and Health Research   (Australia)

^g AUSTIN HEALTH   (Australia)

Author keywords

Carrier screening; Cystic fibrosis; Education; High school; Jewish; Multi disease screening; Tay Sachs disease

Indexed keywords

ADOLESCENT; ANXIETY; ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; DISEASE CARRIER; FAMILY HISTORY; FEMALE; HEALTH PROGRAM; HIGH SCHOOL STUDENT; HUMAN; HUMAN EXPERIMENT; JEW; KNOWLEDGE; MALE; MEDICAL INFORMATION; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING; TAY SACHS DISEASE; AUSTRALIA; EVALUATION STUDY; GENETIC DISEASES, INBORN; GENETIC SCREENING; GENETICS; HETEROZYGOTE DETECTION; PATIENT ATTITUDE; PROCEDURES; PSYCHOLOGY; STUDENT; TAY-SACHS DISEASE;

ADOLESCENT; AUSTRALIA; GENETIC DISEASES, INBORN; GENETIC TESTING; HETEROZYGOTE DETECTION; HUMANS; JEWS; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; STUDENTS; TAY-SACHS DISEASE;

EID: 77954573468     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2010.01459.x     Document Type: Article

References (26)

1. Godard B, ten Kate LP, Evers-Kiebooms G. Population genetic screening programmes: principles, techniques, practices, and policies. Eur J Hum Genet 2003, 11(2):S49-S87.
2. Eur J Hum Genet 2000, 8:998-1000. EUROGAPPP Project 1998-2000 Public and Professional Policy Committee (PPPC): Population genetic screening programmes: Proposed recommendations of the European Society of Human Genetics.
3. Ostrer H. A genetic profile of contemporary Jewish populations. Nat Rev Genet 2001, 2(11):891-898.
4. Raz AE. Can population-based carrier screening be left to the community? J Genet Couns 2009, 18:114-118.
5. Gason AA, Sheffield E, Bankier A. Evaluation of a Tay Sachs disease screening program. Clin Genet 2003, 63:386-392.
6. Barlow-Stewart K, Burnett L, Proos A. A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students. J Med Genet 2003, 40(4):45-52.
7. Kaback MM, Lim-Steele J, Dabholkar D. Tay-Sachs disease - carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The international TSD Data Collection Network. J Am Med Assoc 1993, 270(19):2307-2315.
8. Bach G, Tomczak J, Risch N. Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure. Am J Med Genet 2001, 99(1):70-75.
9. Broide E, Zeigler M, Ekstein J. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel. Am J Med Genet 1993, 47(2):213-215.
10. Ross LF. Heterozygote carrier testing in high schools abroad: What are the lessons for the U.S.? J Law Med Ethics 2006, 34:753-764.
11. Zeesman R, Clow CL, Cartier L. A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal. Am J Med Genet 1984, 18(4):769-778.
12. Gason AA, Metcalfe SA, Delatycki MB. Tay Sachs disease carrier screening in schools: educational alternatives and cheekbrush sampling. Genet Med 2005, 7(9):626-632.
13. Leib JR, Gollust SE, Chandros Hull S. Carrier screening panels for Ashkenazi Jews: Is more better? Genet Med 2005, 7(3):185-190.
14. Prenatal and preconceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent. Obstet Gynecol 2004, 104(2):425-428. ACOG Committee Opinion No. 298
15. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992, 31:301-306.
16. Clow CL, Scriver CR. Knowledge about and attitudes towards genetic screening among high-school students: the Tay-Sachs experience. Pediatrics 1977, 59:86-91.
17. Mitchell JJ, Capua A, Clow C. Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools. Am J Hum Genet 1996, 59:793-798.
18. Eng CM, Schechter C, Robinowitz J. Prenatal genetic carrier testing using triple disease screening. J Am Med Assoc 1997, 278(15):1268-1272.
19. Clarke JTR. Screening for carriers of Tay Sachs disease: two approaches. Can Med Assoc J 1978, 119:549-550.
20. Kornreich R, Ekstein J, Edelmann L. Premarital and prenatal screening for cystic fibrosis: experience in the Ashkenazi Jewish population. Genet Med 2004, 6(5):415-420.
21. Delatycki MB, Wolthuizen M, Collins V. Implementation of ironXS: a study of the acceptability and feasibility of genetic screening for hereditary hemochromatosis in high schools. Clin Genet 2010, 77:241-248.
22. Gason AA, Delatycki MB, Metcalfe SA. It's 'back to school' for genetic screening. Eur J Hum Genet 2006, 14:384-389.
23. Melton GB. Toward " personhood" for adolescents: Autonomy and privacy as values in public policy. Am Psychol 1983, 38(1):99-103.
24. Slaytor EK, Ward JE. How risks of breast cancer and benefits of screening are communicated to women: analysis of 58 pamphlets. Br Med J 1998, 317(7153):263-264.
25. Slater DN. Are women sufficiently well informed to provide valid consent for the cervical smear test? Cytopathology 2000, 11(3):166-170.
26. Levenson D. New test could make carrier screening more accessible. Am J Med Genet 2010, 152A((4)):vii-viii.